SCHEMBL3169972

SCHEMBL3169972

CSc1ncc(-c2sc(C(=O)c3ccc4cc(-c5ccccc5)n(CCCCN)c4c3)cc2CC(=O)NO)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 5/20 0.35
MTNR1A P48039 2/20 0.33
MTNR1B P49286 2/20 0.33
NTRK3 Q16288 2/20 0.32
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
TYK2 P29597 1/20 0.31
JAK3 P52333 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3177728 0.91 NTRK1 (0.36) NTRK1MTNR1AMTNR1BNTRK3JAK2
SCHEMBL3164473 0.90 MTNR1A (0.38) NTRK1MTNR1AMTNR1BNTRK3JAK2
SCHEMBL15117543 0.90 KMT2A (0.36) NTRK1MTNR1AMTNR1BNTRK3JAK2
SCHEMBL3171894 0.89 NTRK1 (0.34) NTRK1MTNR1AMTNR1BNTRK3JAK2
Hydrochloric Acid SCHEMBL3063391 0.89 MTNR1A (0.36) NTRK1MTNR1AMTNR1BNTRK3JAK2
SCHEMBL15117536 0.89 MTNR1A (0.36) NTRK1MTNR1AMTNR1BNTRK3JAK2
Hydrochloric Acid SCHEMBL3049509 0.88 MTNR1A (0.35) NTRK1MTNR1AMTNR1BNTRK3JAK2
Hydrochloric Acid SCHEMBL3049516 0.88 MTNR1A (0.35) NTRK1MTNR1AMTNR1BNTRK3JAK2
SCHEMBL3170821 0.88 NTRK1 (0.38) NTRK1MTNR1AMTNR1BNTRK3JAK2
SCHEMBL3173603 0.87 NTRK1 (0.37) NTRK1MTNR1AMTNR1BNTRK3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492428-B2 Small-molecule botulinum toxin inhibitors MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-07-23 US claimed
US-8492428-B2 Small-molecule botulinum toxin inhibitors MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-07-23 US disclosed
US-20100260778-A1 SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100260778-A1 SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS BTD, RAC2, BTN3A1 NTRK1 449/4885MTNR1A 992/4885MTNR1B 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.